UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030317
Receipt number R000034621
Scientific Title Related examination of the serum gastrin level of patients with gastroesophageal reflux disease in the acid-secreting suppressant administration treatment and the intragastric acid kinetics of secretion
Date of disclosure of the study information 2017/12/08
Last modified on 2017/12/08 16:26:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Related examination of the serum gastrin level of patients with gastroesophageal reflux disease in the acid-secreting suppressant administration treatment and the intragastric acid kinetics of secretion

Acronym

Related examination of the serum gastrin level of patients with gastroesophageal reflux disease in the acid-secreting suppressant administration treatment and the intragastric acid kinetics of secretion

Scientific Title

Related examination of the serum gastrin level of patients with gastroesophageal reflux disease in the acid-secreting suppressant administration treatment and the intragastric acid kinetics of secretion

Scientific Title:Acronym

Related examination of the serum gastrin level of patients with gastroesophageal reflux disease in the acid-secreting suppressant administration treatment and the intragastric acid kinetics of secretion

Region

Japan


Condition

Condition

The acid-secreting suppressant-resistant GERD patients

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We examine the association of the ratio in patients with treated gastroesophageal reflux disease eight weeks or more with PPI and P-CAB standard dose at under intragastric pH 4 time for serum gastrin level and 24 hours.

Basic objectives2

Others

Basic objectives -Others

We perform 24pHMII for the purpose of gastroesophageal reflux dynamics associated with the onset of symptom of subjects and intragastric acid drying effect.

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Serum gastrin level of the acid-secreting suppressant-resistant GERD patients

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

atients with GERD symptom survival that the patients who gastroesophageal reflux disease was diagnosed in this hospital, and received treatment eight weeks or more with PPI or P-CAB standard dose showed more than two points in GERDQ

Key exclusion criteria

The patients with a history of the following disease or the patients who merge now
Zollinger -Ellison syndrome ,Oesophageal stenosis ,Serious esophagus dyskinesia including the achalasia symptom ,Cerebrovascular disorder such as cerebral hemorrhage, cerebral infarction. The Helicobacter pylori infection history patients.
The patients who have difficulty in participation in this study by a merger with serious hepatic disorder, renal disease, heart disorder .A malignant lesion was confirmed; or is the patients with suspected malignant lesion. A pregnant woman, nursing mother or the woman who may be pregnant .In addition, the patients who judged that clinical studies responsibility physician or the study medical attendant was inadequate

Target sample size

500


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Funaki Yasushi

Organization

Department of Intermal Medicine Aichi Medical University

Division name

Division of Gastroenterology

Zip code


Address

1-1Yazakokarimata,Nagakute,Aichi

TEL

0561-62-3311

Email

momomaru@aichi-med-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Funaki Yasushi

Organization

Department of Intermal Medicine Aichi Medical University

Division name

Division of Gastroenterology

Zip code


Address

1-1Yazakokarimata,Nagakute,Aichi

TEL

0561-62-3311

Homepage URL


Email

momomaru@aichi-med-u.ac.jp


Sponsor or person

Institute

Department of Intermal Medicine Aichi Medical University

Institute

Department

Personal name



Funding Source

Organization

Department of Intermal Medicine Aichi Medical University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

愛知医科大学病院(愛知県)


Other administrative information

Date of disclosure of the study information

2017 Year 12 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2017 Year 11 Month 21 Day

Date of IRB


Anticipated trial start date

2017 Year 12 Month 08 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

non


Management information

Registered date

2017 Year 12 Month 08 Day

Last modified on

2017 Year 12 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034621